384 related articles for article (PubMed ID: 20166766)
21. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous T-cell lymphoma: a paradigm for biological therapies.
Pichardo DA; Querfeld C; Guitart J; Kuzel TM; Rosen ST
Leuk Lymphoma; 2004 Sep; 45(9):1755-65. PubMed ID: 15223633
[TBL] [Abstract][Full Text] [Related]
23. The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches.
Weiner DM; Durgin JS; Wysocka M; Rook AH
J Am Acad Dermatol; 2021 Mar; 84(3):597-604. PubMed ID: 33352268
[TBL] [Abstract][Full Text] [Related]
24. Antibody-Based Therapies for Cutaneous T-Cell Lymphoma.
Welborn M; Duvic M
Am J Clin Dermatol; 2019 Feb; 20(1):115-122. PubMed ID: 30430444
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic advances in cutaneous T-cell lymphoma.
Akilov OE; Geskin L
Skin Therapy Lett; 2011 Feb; 16(2):1-5. PubMed ID: 21591544
[TBL] [Abstract][Full Text] [Related]
26. Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).
Bunn PA; Hoffman SJ; Norris D; Golitz LE; Aeling JL
Ann Intern Med; 1994 Oct; 121(8):592-602. PubMed ID: 8085692
[TBL] [Abstract][Full Text] [Related]
27. Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.
Foss F
Leuk Lymphoma; 2003; 44 Suppl 3():S55-61. PubMed ID: 15202526
[TBL] [Abstract][Full Text] [Related]
28. Interventions for mycosis fungoides.
Valipour A; Jäger M; Wu P; Schmitt J; Bunch C; Weberschock T
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008946. PubMed ID: 32632956
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous T cell lymphoma.
Dummer R; Vermeer MH; Scarisbrick JJ; Kim YH; Stonesifer C; Tensen CP; Geskin LJ; Quaglino P; Ramelyte E
Nat Rev Dis Primers; 2021 Aug; 7(1):61. PubMed ID: 34446710
[TBL] [Abstract][Full Text] [Related]
30. Novel therapies for cutaneous T-cell lymphoma: what does the future hold?
Guenova E; Hoetzenecker W; Rozati S; Levesque MP; Dummer R; Cozzio A
Expert Opin Investig Drugs; 2014 Apr; 23(4):457-67. PubMed ID: 24397291
[TBL] [Abstract][Full Text] [Related]
31. Bexarotene in the treatment of cutaneous T-cell lymphoma.
Querfeld C; Nagelli LV; Rosen ST; Kuzel TM; Guitart J
Expert Opin Pharmacother; 2006 May; 7(7):907-15. PubMed ID: 16634713
[TBL] [Abstract][Full Text] [Related]
32. Topical and systemic retinoid therapy for cutaneous T-cell lymphoma.
Kempf W; Kettelhack N; Duvic M; Burg G
Hematol Oncol Clin North Am; 2003 Dec; 17(6):1405-19. PubMed ID: 14710892
[TBL] [Abstract][Full Text] [Related]
33. Staging and management of cutaneous T-cell lymphoma.
Scarisbrick JJ
Clin Exp Dermatol; 2006 Mar; 31(2):181-6. PubMed ID: 16487086
[TBL] [Abstract][Full Text] [Related]
34. [Current therapy concepts in cutaneous T-cell lymphomas].
Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
[TBL] [Abstract][Full Text] [Related]
35. Optimal combination with PUVA: rationale and clinical trial update.
Stadler R
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):29-32. PubMed ID: 17474357
[TBL] [Abstract][Full Text] [Related]
36. Forodesine in the treatment of cutaneous T-cell lymphoma.
Lewis DJ; Duvic M
Expert Opin Investig Drugs; 2017 Jun; 26(6):771-775. PubMed ID: 28447489
[TBL] [Abstract][Full Text] [Related]
37. An oncologist's approach to therapy for cutaneous T-cell lymphoma.
Foss FM
Clin Lymphoma; 2000 Nov; 1 Suppl 1():S9-14. PubMed ID: 11707857
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous T cell lymphoma: update on treatment.
Wollina U
Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
[TBL] [Abstract][Full Text] [Related]
39. Current management strategies for cutaneous T-cell lymphoma.
Knobler E
Clin Dermatol; 2004; 22(3):197-208. PubMed ID: 15262305
[TBL] [Abstract][Full Text] [Related]
40. Existing and Emerging Therapies for Cutaneous T-Cell Lymphoma.
Van-de-Velde V; Zhou Y
J Cutan Med Surg; 2019; 23(3):319-327. PubMed ID: 30943788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
